Redenlab ataxia experience

box-icon

Sites

40

box-icon

Patients

500

box-icon

Languages

14

box-icon

Clinical trials

10+

box-icon

Natural history studies

10+

    Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for Ataxia Research...
      Redenlab’s CEO, Adam Vogel, co-wrote "The Role of Verbal Fluency in the Cerebellar Cognitive Affective Syndrome Scale in Friedreich Ataxia"...
        Spinocerebellar ataxia Type 1 (SCA1) is a dominantly inherited neurodegenerative disease resulting in balance, speech, thinking and coordination difficulties. SCA1...
          A recent study published in iScience explores the effects of KAT6B overexpression in mice, shedding light on the behavioral implications...
            Batten disease, or neuronal ceroid lipofuscinosis (NCL), is a devastating childhood dementia that causes progressive loss of speech, language, and...
              Redenlab is dedicated to advancing research in the field of speech, language, and cognitive disorders, particularly in the context of...